DiaMedica Therapeutics Inc.
DMAC
$5.67
-$0.13-2.24%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.56% | 0.62% | 0.19% | -15.43% | 0.13% |
| Total Depreciation and Amortization | 0.00% | 25.00% | 0.00% | 0.00% | 14.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.15% | -19.21% | 65.42% | 463.16% | -88.82% |
| Change in Net Operating Assets | 252.35% | 126.50% | -236.71% | 449.58% | 51.64% |
| Cash from Operations | 1.08% | 32.08% | -74.53% | 20.53% | 4.63% |
| Capital Expenditure | -- | 100.00% | -200.00% | 70.00% | -150.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -217.74% | 12.31% | -31.17% | 408.04% | 104.29% |
| Cash from Investing | -217.93% | 12.55% | -31.29% | 412.04% | 104.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | -100.00% | 0.00% | 50.00% | 0.00% |
| Issuance of Common Stock | -98.93% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.95% | 1,175,300.00% | 0.00% | 83.33% | -100.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.98% | 589.33% | -205.84% | 164.07% | -197.70% |
